Rob Koster

Software Engineer at Locsense

Rob Koster is a seasoned software engineer with extensive experience in embedded and application software development. Currently employed at Locsense since November 2024, Rob contributes to innovative software solutions. Previously, at Movella from November 2019 to October 2024, Rob held positions as Principal Application Software Engineer and Senior Software Application Engineer, focusing on digitizing movement through advanced technology. Prior roles include Systeemontwikkelaar at Ardanta from April 2014 to November 2019 and Software Developer at Locamation from November 2012 to March 2014. Rob Koster holds a Bachelor of Science in Electrical Engineering from the University of Twente and completed VWO with a focus on Nature and Technology at Stad en Esch in Meppel.

Location

Boekelo, Netherlands

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Locsense

Locsense develops and supplies barrier integrity monitoring equipment for early stage research in the pharmaceutical, food and cosmetics industry. Our flagship device, the Locsense Artemis, is a non-invasive sensor that monitors cell growth and cell health in conventional transwell plates with inserts. Locsense is at the forefront of lab technology with devices that non-invasively monitor and test cells outside the body. In our bodies, cells often form protective barriers. Think of these barriers as tiny walls that separate different areas. For example, the lining of your gut has cells that create a barrier between your food and the rest of your body, or the skin which forms a protective barrier for influences from outside. Impedance measurements offer a way to measure how strong these barriers are and whether they are intact. The Artemis offers insight into how healthy cell barriers are. This is crucial for drug testing, studying diseases, and making sure our body’s defenses work properly. Our products are designed to combine with conventional workflow. At the same time they can be coupled to innovative in-vitro cell culture platforms, such as microfluidic chips, organs-on-chip or smartplates.


Employees

1-10

Links